Baldry Mark (CIK 1644137) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-06-03). Recent activity: Buy XFOR (1,032 shares), Buy XFOR (1,032 shares), Buy XFOR (21,646 shares), Buy XFOR (13,404 shares), Buy XFOR (600,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-06-03 | X4 Pharmaceuticals, Inc (XFOR) | Chief Commercial Officer | Buy | 1,032 | $2,559 |
| 2025-05-20 | X4 Pharmaceuticals, Inc (XFOR) | Chief Commercial Officer | Buy | 1,032 | $2,559 |
| 2025-02-14 | X4 Pharmaceuticals, Inc (XFOR) | Chief Commercial Officer | Buy | 21,646 | $0 |
| 2025-02-14 | X4 Pharmaceuticals, Inc (XFOR) | Chief Commercial Officer | Buy | 13,404 | $0 |
| 2025-02-14 | X4 Pharmaceuticals, Inc (XFOR) | Chief Commercial Officer | Buy | 600,000 | $0 |
| 2025-01-27 | X4 Pharmaceuticals, Inc (XFOR) | Chief Commercial Officer | Buy | 74,773 | $0 |
| 2025-01-27 | X4 Pharmaceuticals, Inc (XFOR) | Chief Commercial Officer | Sell | 29,159 | $0 |
Source: SEC Form 4 filings · as of 2025-06-03